Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 22K
6: R1 Cover HTML 49K
8: XML IDEA XML File -- Filing Summary XML 11K
11: XML XBRL Instance -- ivc-20240304_htm XML 13K
7: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
3: EX-101.DEF XBRL Definitions -- ivc-20240304_def XML 52K
4: EX-101.LAB XBRL Labels -- ivc-20240304_lab XML 89K
5: EX-101.PRE XBRL Presentations -- ivc-20240304_pre XML 52K
2: EX-101.SCH XBRL Schema -- ivc-20240304 XSD 10K
9: JSON XBRL Instance as JSON Data -- MetaLinks 15± 23K
10: ZIP XBRL Zipped Folder -- 0000742112-24-000010-xbrl Zip 18K
(Address of principal executive offices) (Zip Code)
i(440)i329-6000
(Registrant’s telephone
number, including area code)
None
————————————————————————————————
(Former name or former address, if changed since last report.)
————————————————————————————————————
Securities registered pursuant to Section 12(b) of the Exchange Act: None
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i☐ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 4, 2024, the Board of Directors (the “Board”) of Invacare Holdings Corporation (the “Company”) appointed to the Audit Committee Mr. Samuel Brill, who was appointed as Chair, and Messrs.
Jame Donath and J. Carney Hawks. Further, on March 5, 2024, the Board appointed Messrs. Brill, Donath and Hawks to the Compensation, Nominating and Governance Committee.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number
Description
104
Cover
Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.